These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 26907161)
1. Structures of Trypanosome Vacuolar Soluble Pyrophosphatases: Antiparasitic Drug Targets. Yang Y; Ko TP; Chen CC; Huang G; Zheng Y; Liu W; Wang I; Ho MR; Hsu ST; O'Dowd B; Huff HC; Huang CH; Docampo R; Oldfield E; Guo RT ACS Chem Biol; 2016 May; 11(5):1362-71. PubMed ID: 26907161 [TBL] [Abstract][Full Text] [Related]
2. Macromolecular Targets of Antiparasitic Germacranolide Sesquiterpenoids: An Arnston PM; Setzer WN Comb Chem High Throughput Screen; 2020; 23(6):477-503. PubMed ID: 32067612 [TBL] [Abstract][Full Text] [Related]
3. Design and preparation of sterol mimetics as potential antiparasitics. Gigante F; Kaiser M; Brun R; Gilbert IH Bioorg Med Chem; 2010 Oct; 18(20):7291-301. PubMed ID: 20846867 [TBL] [Abstract][Full Text] [Related]
4. Structural and Functional Highlights of Vacuolar Soluble Protein 1 from Pathogen Trypanosoma brucei brucei. Jamwal A; Round AR; Bannwarth L; Venien-Bryan C; Belrhali H; Yogavel M; Sharma A J Biol Chem; 2015 Dec; 290(51):30498-513. PubMed ID: 26494625 [TBL] [Abstract][Full Text] [Related]
5. Sterol 14alpha-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasis. Lepesheva GI; Waterman MR Curr Top Med Chem; 2011; 11(16):2060-71. PubMed ID: 21619513 [TBL] [Abstract][Full Text] [Related]
6. Bisphosphonate inhibition of the exopolyphosphatase activity of the Trypanosoma brucei soluble vacuolar pyrophosphatase. Kotsikorou E; Song Y; Chan JM; Faelens S; Tovian Z; Broderick E; Bakalara N; Docampo R; Oldfield E J Med Chem; 2005 Sep; 48(19):6128-39. PubMed ID: 16162013 [TBL] [Abstract][Full Text] [Related]
7. 2-alkylaminoethyl-1,1-bisphosphonic acids are potent inhibitors of the enzymatic activity of Trypanosoma cruzi squalene synthase. Rodrígues-Poveda CA; González-Pacanowska D; Szajnman SH; Rodríguez JB Antimicrob Agents Chemother; 2012 Aug; 56(8):4483-6. PubMed ID: 22585217 [TBL] [Abstract][Full Text] [Related]
8. Applicability of plant-based products in the treatment of Trypanosoma cruzi and Trypanosoma brucei infections: a systematic review of preclinical in vivo evidence. Pereira RM; Greco GMZ; Moreira AM; Chagas PF; Caldas IS; Gonçalves RV; Novaes RD Parasitology; 2017 Sep; 144(10):1275-1287. PubMed ID: 28578742 [TBL] [Abstract][Full Text] [Related]
9. Vinyl sulfones as antiparasitic agents and a structural basis for drug design. Kerr ID; Lee JH; Farady CJ; Marion R; Rickert M; Sajid M; Pandey KC; Caffrey CR; Legac J; Hansell E; McKerrow JH; Craik CS; Rosenthal PJ; Brinen LS J Biol Chem; 2009 Sep; 284(38):25697-703. PubMed ID: 19620707 [TBL] [Abstract][Full Text] [Related]
10. Bisphosphonate-Based Molecules as Potential New Antiparasitic Drugs. Branco Santos JC; de Melo JA; Maheshwari S; de Medeiros WMTQ; de Freitas Oliveira JW; Moreno CJ; Mario Amzel L; Gabelli SB; Sousa Silva M Molecules; 2020 Jun; 25(11):. PubMed ID: 32503272 [TBL] [Abstract][Full Text] [Related]
11. Toward the development of dual-targeted glyceraldehyde-3-phosphate dehydrogenase/trypanothione reductase inhibitors against Trypanosoma brucei and Trypanosoma cruzi. Belluti F; Uliassi E; Veronesi G; Bergamini C; Kaiser M; Brun R; Viola A; Fato R; Michels PA; Krauth-Siegel RL; Cavalli A; Bolognesi ML ChemMedChem; 2014 Feb; 9(2):371-82. PubMed ID: 24403089 [TBL] [Abstract][Full Text] [Related]
12. Structural characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei bound to the antifungal drugs posaconazole and fluconazole. Chen CK; Leung SS; Guilbert C; Jacobson MP; McKerrow JH; Podust LM PLoS Negl Trop Dis; 2010 Apr; 4(4):e651. PubMed ID: 20386598 [TBL] [Abstract][Full Text] [Related]
13. A binding hotspot in Trypanosoma cruzi histidyl-tRNA synthetase revealed by fragment-based crystallographic cocktail screens. Koh CY; Siddaramaiah LK; Ranade RM; Nguyen J; Jian T; Zhang Z; Gillespie JR; Buckner FS; Verlinde CL; Fan E; Hol WG Acta Crystallogr D Biol Crystallogr; 2015 Aug; 71(Pt 8):1684-98. PubMed ID: 26249349 [TBL] [Abstract][Full Text] [Related]
14. Fragment-based screening in tandem with phenotypic screening provides novel antiparasitic hits. Blaazer AR; Orrling KM; Shanmugham A; Jansen C; Maes L; Edink E; Sterk GJ; Siderius M; England P; Bailey D; de Esch IJ; Leurs R J Biomol Screen; 2015 Jan; 20(1):131-40. PubMed ID: 25231971 [TBL] [Abstract][Full Text] [Related]